OrthoPediatrics (KIDS)
(Delayed Data from NSDQ)
$32.60 USD
-0.26 (-0.79%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $32.66 +0.06 (0.18%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
KIDS 32.60 -0.26(-0.79%)
Will KIDS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for KIDS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KIDS
OrthoPediatrics (KIDS) Soars 7.5%: Is Further Upside Left in the Stock?
CVRx (CVRX) Stock Jumps 33.9%: Will It Continue to Soar?
KIDS: What are Zacks experts saying now?
Zacks Private Portfolio Services
OrthoPediatrics (KIDS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for KIDS
OrthoPediatrics Corp. to Report Second Quarter 2024 Financial Results on August 6, 2024
OrthoPediatrics price target lowered by $3 at Truist, here's why
OrthoPediatrics Breaks Below 200-Day Moving Average - Notable for KIDS
Analysts Offer Insights on Healthcare Companies: OrthoPediatrics (KIDS), Pharvaris (PHVS) and Cue Biopharma (CUE)
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference